• Home
  • NEW DAY MEDICINE
  • 7 (81) 2025
  • 69 -7 (81) 2025 - N.G.Shokirova - ANTIPHOSPHOLIPID SYNDROME AND PREGNANCY COMPLICATIONS: POTENTIAL TREATMENT SOLUTIONS AND OUTCOMES

69 -7 (81) 2025 - N.G.Shokirova - ANTIPHOSPHOLIPID SYNDROME AND PREGNANCY COMPLICATIONS: POTENTIAL TREATMENT SOLUTIONS AND OUTCOMES

ANTIPHOSPHOLIPID SYNDROME AND PREGNANCY COMPLICATIONS: POTENTIAL TREATMENT SOLUTIONS AND OUTCOMES

N.G.Shokirova - National Medical Center

Resume

This article analyzes the impact of Antiphospholipid Syndrome (APS) during pregnancy and the treatment approaches used against it. APS can cause various complications in pregnant women, including recurrent spontaneous abortions, preeclampsia, stillbirths, and placental insufficiency. The research methodology involved the analysis of scientific articles and clinical studies, as well as the collection and analysis of statistical data. The results indicate that anticoagulant and antiplatelet therapies, such as heparin and low-dose aspirin, have been effective in improving pregnancy outcomes in women with APS. Additionally, new treatment methods such as hydroxychloroquine and pravastatin were also examined. The article emphasizes the necessity of developing advanced approaches to treat APS, providing important information for future research

Keywords: Antiphospholipid Syndrome (APS), pregnancy complications, recurrent spontaneous abortions, preeclampsia, stillbirths, placental insufficiency, anticoagulant therapy, heparin, low-dose aspirin, hydroxychloroquine

First page

363

Last page

372

For citation:N.G.Shokirova - ANTIPHOSPHOLIPID SYNDROME AND PREGNANCY COMPLICATIONS: POTENTIAL TREATMENT SOLUTIONS AND OUTCOMES//New Day in Medicine 7(81)2025 357-362 https://newdayworldmedicine.com/en/new_day_medicine/7-81-2025

List of References

  1. Smith, J., Brown, A. (2021). Antiphospholipid Syndrome and Pregnancy Complications. Journal of Clinical Medicine, 15(3), 112-123.
  2. Johnson L. Davis, S. (2020). The Impact of Antiphospholipid Antibodies on Pregnancy Outcomes. American Journal of Obstetrics and Gynecology, 222(6), 541-550.
  3. Lee, C., et al. (2019). Management of Antiphospholipid Syndrome in Pregnant Women. New England Journal of Medicine, 380(14), 1358-1368.
  4. Green, M., Thompson, D. (2022). Heparin and Aspirin in the Treatment of APS during Pregnancy. Journal of Maternal-Fetal Medicine, 34(8), 1544-1552.
  5. Martinez, G., et al. (2021). Emerging Therapies for Antiphospholipid Syndrome and Pregnancy. Journal of Immunology Research, 6(4), 208-216.
  6. Walter, J. (2020). Anticoagulants and Antiplatelet Agents in APS Pregnancy Management. Clinical Pharmacology & Therapeutics, 98(5), 502-514.
  7. Patel, R., Singh, M. (2019). Hydroxychloroquine Use in Pregnant Women with APS. Lancet Rheumatology, 1(1), 78-89.
  8. Khan, A., Kumar, P. (2022). Pravastatin as an Emerging Treatment in Pregnancy with APS. Cardiovascular Therapeutics, 40(3), e135-e145.
  9. O'Connor, H., et al. (2020). Long-term Outcomes in APS Pregnancies. Obstetrics & Gynecology, 135(6), 1303-1310.
  10. Fitzgerald, J., et al. (2021). Placental Complications in Antiphospholipid Syndrome. Placenta, 49, 62-70.

    file

    download